Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Analysis
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Sustainability

Karolinska Institutet

www.ki.se

Nobels vag 5
Solna
Stockholm
SE-171 77
Sweden

+45 8 524 800 00

Activities

Research & Development

Related Companies

  • Icrom SRL
  • Nanoform
  • Starlab
  • PCI Pharma Services
  • Solvias
  • Piramal Pharma Solutions
  • Butterworth Laboratories
  • Hermes Pharma GmbH
  • Ecolab Life Sciences
  • Vectorbuilder Inc
  • Indena
  • Quotient Sciences
  • ProtaGene
  • Actylis – The Partner of Choice

Related Content

Partnership to validate clinical antimicrobial susceptibility testing
Partnership to validate clinical antimicrobial susceptibility testing
Zika outbreak gives rise to global fears
Zika outbreak gives rise to global fears
Scancell embarks on strategic collaboration with a world-leading research team at the Karolinska Institutet
Scancell embarks on strategic collaboration with a world-leading research team at the Karolinska Institutet
Ferring and Karolinska Institutet to develop human microbiome translational research programme
Ferring and Karolinska Institutet to develop human microbiome translational research programme
EU funds ovarian cancer research with €6m
EU funds ovarian cancer research with €6m
European cancer centres finally united in long-term collaborative partnerships
European cancer centres finally united in long-term collaborative partnerships
Karolinska researchers develop method to measure extent to which drugs reach their targets
Karolinska researchers develop method to measure extent to which drugs reach their targets
AstraZeneca and Karolinska Institutet to create Integrated Translational Research Centre
AstraZeneca and Karolinska Institutet to create Integrated Translational Research Centre
Newron to acquire NeuroNova for €15.4m
Newron to acquire NeuroNova for €15.4m
Karolinska Institute develops new type of anticancer drug
Karolinska Institute develops new type of anticancer drug
Low levels of natural antibodies increase stroke risk
Low levels of natural antibodies increase stroke risk
  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company